The launch of fIVE DB facilitates calibration of biomodels

NEWS
Press-Release
Software
December 16, 2021

[Moscow – 16.12.2021] InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, now presents its new QSP modeling tool, fIVE DB. The name of the database derives from In Vitro Experiments DataBase (fIVE DB). fIVE DB is a repository of kinetic data for Systems Biology Modeling. Its purpose is to facilitate calibration of biomodels based on in vitro data.


fIVE DB was initially presented in frames of Twelfth American Conference on Pharmacometrics (ACoP12). Alexander Stepanov, Head of the new project highlights, “We consider that the information provided by fIVE DB allows to boost and facilitate parameters identification for development of QSP models”. fIVE DB contains experimental datasets manually extracted from published literature and converted into kinetic parameters that describe cellular processes such as migration, proliferation, differentiation, death and secretion of cellular products. fIVE DB is being constantly expanded to include new in vitro experiments and effector regulation network.


fIVE DB stores kinetic parameters (kbase, Emax, Imax, EC50, IC50 etc.) and its experimental context. An approach for translating in vitro and ex vivo experiments into kinetic constants is developed by InSysBio. fIVE DB is designed to be searched for kinetic data based on the cell type, reactions, effectors and modifiers, or for their various combinations. Users can browse and search the content of the repository, and download results in CSV format. Moreover, data collected in fIVE DB provides a good start point for model calibration.


Key features of fIVE DB:
• Search by cell or by process type;
• The query may include effector (activator or inhibitor) or effector’s modifier, type of kinetic constant;
• Table/CSV format representation of the search results.


InSysBio team has developed its own QSP infrastructure that includes both services and software products. However, its further advancement and extension is underway. The launch of fIVE DB is a new step to provide QSP community with cutting-edge work environment and make modeling process more efficient for both external and internal modelers. More information about fIVE DB can be found at 5db.insysbio.com.
High five!

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

June 2020
MoTuWeThFrSaSu
1
2
1. 02 Jun 2020 13:24 InSysBio to announce the launch of QSP model of COVID-19 The new open source project to be developed and updated Online InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces the launch of its fundamentally new project in response to the ongoing global threat, the open source QSP model of COVID-19. In accordance with its mission, which is to assist pharmaceutical industry to speed up the delivery of the cure to patients, InSysBio team could not stay aside. Thus, the aim of the new project is to develop QSP model of COVID-19 describing virus and host cell life cycles, innate and adoptive immune response and possible therapeutic treatments.
3
4
5
1. 05 Jun 2020 15:04 InSysBio to present IRT Navigator 3 InSysBio presents IRT Navigator 3 which is an application software providing intuitive interface to work with the Immune Response Template Database in accordance with the user’s needs. It supplies the navigation within the schemes and components and efficient development of QSP models based on IRT Database.
6
7
8
1. 08 Jun 2020 15:30 InSysBio to perform the first step in development of COVID-19 QSP model InSysBio has performed the first step in the direction of development of QSP model of COVID-19 describing virus and host cell life cycles, innate and adoptive immune response and possible therapeutic treatments.
9
10
11
12
1. 12 Jun 2020 16:45 InSysBio to release the new version of Cytocon DB 1.1.6.4 We are glad to announce the release of the new version of Cytocon DB 1.1.6.4. The DB was significantly extended with new data due to well-coordinated workflow of Cytocon DB team and its new members. Namely, 54 diseases, 24 tissues, 42 molecules, 24 cells and 3701 concentrations were introduced.
13
14
15
16
17
1. 17 Jun 2020 15:48 InSysBio to welcome its new team member Dr. Neil Benson InSysBio announces the appointment of Dr. Neil Benson as Principal Consultant in area of business development (Edinburgh-Moscow-16.06.2020) InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, is proud to announce its new team member Dr. Neil Benson! Dr. Benson has joined InSysBio as Principal Consultant in area of business development of both INSYSBIO LLC and INSYSBIO UK LIMITED. In his capacity as Principal Consultant to InSysBio, he will support further development of the outstanding IO and AD QSP offering of the company.
18
19
20
21
22
1. 22 Jun 2020 17:04 InSysBio team posters to be presented at AACR Virtual Annual Meeting II AACR Virtual Annual Meeting II has begun! American Association for Cancer Research Annual Meeting is held virtually this year on June 22-24 due to COVID-19 spread. Today InSysBio team's posters were published on AACR website
23
24
25
26
27
28
29
30
1. 30 Jun 2020 15:45 InSysBio to present COVID-19 QSP model further development InSysBio continues to move forward in COVID-19 QSP model development. Its aim is to describe virus and host cell life cycles, innate and adoptive immune response and possible therapeutic treatments.
     
Upcoming Events
Tags
Latest News
10.09
InSysBio team to publish the new article in PSPJournal
04.09
InSysBio to launch Immune Response Template version 3.6.3 for QSP modeling
22.02
14th InSysBio’s Annual Internal Scientific Meeting
24.01
InSysBio to present the new Plugin for Sublime Text and Heta compiler Online
07.12
InSysBio to release public beta of fIVE Calculator